ZNTL news

Latest 2 stories · newest Jul 17, 2026

ZNTL
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday
ZNTL
Zentalis announces Phase 1b MUIR trial data for azenosertib plus paclitaxel in ovarian cancer

Zentalis Pharmaceuticals presented Phase 1b MUIR trial results showing 39% overall response rate and 7.3-month median PFS for azenosertib combined with paclitaxel in platinum-resistant ovarian cancer patients. The data demonstrates a manageable safety profile and supports continued development of az…

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same ZNTL feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/ZNTL/newsSTART FREE